The Deadly Effects of Smoking and Secondhand Smoke

Sep.01.2022
The Deadly Effects of Smoking and Secondhand Smoke
Smoking is a leading cause of death in the US, causing chronic obstructive pulmonary disease, asthma and even diabetes. Secondhand smoke is also harmful.

If you smoke, your body will be harmed - we all know that. But did you know that being around people who smoke today can also harm your body?


Smoking is the leading cause of death in the United States. However, it is often attributed to something else medically speaking. Deaths may be attributed to chronic obstructive pulmonary disease, asthma, and even diabetes - conditions that are worsened by smoking or caused by smoking.


If you don't smoke, you are already doing the first thing you can do to prevent these terrible, but preventable diseases. The second thing you can do is to avoid second-hand smoke," said Todd Mahr, an allergist and immunologist as well as an expert on the harmful effects of smoking at the Gunderson Health System. It means that if you are exposed to second-hand smoke, you are constantly in the presence of people who are smoking.


Second-hand smoke is a bigger problem for young children. When discussing third-hand smoke with parents, they often say "I never smoke around them," but the smoke still lingers on their clothing and in the surrounding area, which can still be harmful, according to Mahr. However, there is now one thing you can do to extend your life expectancy.


He said, "Some people don't consider e-cigarettes as smoking. Being unique is important, but being unique doesn't always mean it's a good thing. People say, 'I'm vaping. All I'm inhaling is water vapor.' But in reality, they contain chemicals that can lead to cancer.


This story is part of a series by the Valley Media Group exploring the leading causes of death from 1999 to 2020. The data in this story is sourced from the Centers for Disease Control and Prevention.


The fourth leading cause of death in the area.


Chronic Lower Respiratory Disease (CLRD) encompasses Chronic Obstructive Pulmonary Disease (COPD), including emphysema and chronic bronchitis, as well as asthma, pulmonary hypertension, and occupational lung diseases.


According to data from the Centers for Disease Control and Prevention, it is the sixth leading cause of death in the United States, responsible for 152,657 deaths.


In the valley region, 4,116 people died from CLRD in 2020, making it the fourth leading cause of death in La Crosse County, Vernon County, Dunn County, Trempealeau County, Chippewa County, and Monroe County in Wisconsin, as well as Houston County and Winona County in Minnesota.


Chronic obstructive pulmonary disease (COPD) accounts for the majority of chronic lower respiratory diseases and is primarily caused by smoking in approximately 85% of cases.


Over time, exposure to irritants in cigarette smoke can weaken the lungs' ability to resist infection, leading to tracheal inflammation and damage to air sacs or alveoli. Long-term exposure to air pollution, smoke, chemicals, or secondhand smoke also contributes to the development of chronic obstructive pulmonary disease (COPD), as does vaping e-cigarettes and smoking marijuana. Symptoms of COPD include shortness of breath, wheezing, or chronic coughing.


Chronic obstructive pulmonary disease (COPD) has decreased from being the fourth leading cause of death in the United States in 2018 to the sixth in 2020, but its incidence rate may be higher than expected.


More than 50% of adults with poor lung function are unaware that they have chronic obstructive pulmonary disease, according to a study conducted in 2013.


Dr. Hafiz Fakih, a pulmonary and critical care specialist at the Greater Los Angeles VA Healthcare System, explains that there may be a potential underreporting of deaths related to chronic obstructive pulmonary disease (COPD) due to the condition being listed as the cause of death instead of the actual underlying cause of death.


Fatal consequences


Smoking is terrible. But just how terrible is it?


Mahr states, "The most important thing is that smoking can lead to everything. We are talking about lower respiratory tract diseases, but it can lead to many illnesses and disabilities, actually harming every organ in the body.


Most Americans are aware that smoking has a significant impact on the lungs, but that's not all. According to Mahr, it affects a person's entire body.


Around 16 million Americans suffer from smoking-related diseases, including lung cancer and chronic obstructive pulmonary disease. However, smoking can also lead to or worsen heart disease, stroke, other lung diseases, diabetes, emphysema, and chronic bronchitis. It even increases the risks of tuberculosis and eye diseases and can severely damage our immune systems. From a medical standpoint, smoking can affect everything. In relation to the COVID-19 virus, smoking also increases the risk of infection.


In recent years, there has been a significant decrease in the smoking rates of adults, going from 20.9% in 2005 to 12.5% in 2020. Additionally, smoking rates among youth have dropped from 23% in 2000 to 2.3% in 2021.


According to Fakih, while the mortality rate for men suffering from chronic obstructive pulmonary disease (COPD) has decreased slightly, "the mortality rate for women with COPD is slightly higher," as the rate of female smokers declining is slower than that of men.


Race is also a factor in smoking rates - 21.9% of American Indians and Alaskan Natives smoke, as do 16.8% of African Americans and Blacks. Non-Hispanic white smokers have a slightly lower smoking rate at 16.6%, but their use of menthol cigarettes is only one-third that of African American smokers. Menthol products make smoking more enjoyable and harder to quit.


According to Fakih, we can manage the damage caused by smoking, but we cannot reverse it. When you quit smoking, the harm will come to an end.


The COVID-19 pandemic has heightened people's awareness of lung diseases. According to Mahr, it is now evident that simply wearing a mask every day is not the straightforward solution for calming lung infections and chronic illnesses.


It all depends on your personal risk factors. Respiratory illnesses are not very common, and most people would attribute them to community-acquired pneumonia and bronchitis. However, they are still fatal. Look at the statistics. Many people are struggling for their lives," Mahr said. "We know that one thing that increases your risk of disease and death is smoking. People should be aware of this. If possible, quit.


Disclaimer: 1. The content of this article is compiled from third-party information and is intended for industry exchange and learning purposes only. 2. The views expressed in this article do not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity and accuracy of the content of the article. The compilation of this article is only for industry exchange and research purposes. 3. Due to limited compiling skills, the compiled article may not fully express the original article, please refer to the original article for accuracy. 4. 2FIRSTS fully supports the Chinese government on any statements and positions related to domestic, Hong Kong, Macau, Taiwan, and foreign affairs. 5. The copyright of the compiled information belongs to the original media and author, and if there is any infringement, please contact us for deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

PMI U.S. White Paper Calls for Greater Access to FDA-Authorized Smoke-Free Alternatives and Risk-Based Taxation
PMI U.S. White Paper Calls for Greater Access to FDA-Authorized Smoke-Free Alternatives and Risk-Based Taxation
PMI’s U.S. business released a white paper and cited a national online survey showing that 79.00% of Americans surveyed believe more should be done to reduce smoking-related harm. The paper calls on policymakers, public health authorities, and medical professionals to place cigarette smoking back at the center of public health priorities, and recommends broader access to FDA-authorized smoke-free alternatives, clearer nicotine risk communication, and risk-based taxation.
Apr.15 by 2FIRSTS.ai
IMF Article Sets Out Three Principles: Cover All Harmful Products, Match Tax Rates to Harm, Improve Cross-Border Coordination
IMF Article Sets Out Three Principles: Cover All Harmful Products, Match Tax Rates to Harm, Improve Cross-Border Coordination
A March 2026 article in Finance & Development, “Taxing Harmful Habits,” argues that taxes on harmful products such as tobacco, alcohol and sugary drinks should better reflect the health harm they cause. The authors propose three principles: capture all harmful products, align tax rates with health harm, and strengthen cross-border coordination to reduce evasion and smuggling.
Mar.24 by 2FIRSTS.ai
Philip Morris Korea to Launch IQOS Iluma i One “Electric Purple” Color, Expanding Into Major Convenience Store Channels From May
Philip Morris Korea to Launch IQOS Iluma i One “Electric Purple” Color, Expanding Into Major Convenience Store Channels From May
Philip Morris Korea said on March 31 that it will begin selling the new “Electric Purple” color for the heated tobacco device IQOS Iluma i One at major convenience stores nationwide in South Korea starting May 2. The color will first be introduced on April 10 at the official IQOS online store and nine IQOS directly operated stores nationwide. To mark the expansion of its sales channels, the company will run promotions at major convenience stores through May 20.
Mar.31
Product | 30ml E-Liquid, 40,000 Puffs, and Three Power Settings: OXBAR Launches New DTL Product ROVOTA
Product | 30ml E-Liquid, 40,000 Puffs, and Three Power Settings: OXBAR Launches New DTL Product ROVOTA
E-cigarette brand OXBAR has launched its new DTL e-cigarette, the OXBAR ROVOTA, on its official website. The product contains 30ml of e-liquid and is officially rated for up to approximately 40,000 puffs. It has a nicotine strength of 6mg and offers around 15 flavor options. The device is equipped with a 1400mAh battery, supports Type-C charging, features a 0.4Ω dual mesh coil, and supports three power settings of 20W, 30W, and 40W.
Mar.31 by 2FIRSTS.ai
Australian Government and Spotify Launch Third Phase of Youth Vaping Education Campaign
Australian Government and Spotify Launch Third Phase of Youth Vaping Education Campaign
The Australian Government and Spotify have launched the third phase of the Youth Vaping Education Campaign under the theme “Buddy Up – Make a Pact to Quit Together.” This phase shifts the focus toward peer and community support by encouraging young people to quit vaping together.
Apr.16 by 2FIRSTS.ai
South Korea Moves Against Synthetic Nicotine Regulatory Gap as Three Companies Face Tobacco Business Act Probe
South Korea Moves Against Synthetic Nicotine Regulatory Gap as Three Companies Face Tobacco Business Act Probe
South Korea’s Ministry of Finance and Economy said on May 4 that it requested the Daejeon Metropolitan Police Agency and Gyeonggi Nambu Provincial Police Agency to investigate three sales companies on suspicion of violating the Tobacco Business Act.
May.06 by 2FIRSTS.ai